Approval · Notice of Compliance 2828 · 1998
VIDEX: Notice of Compliance 2828
Issued June 10, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2828
- Date
- June 10, 1998
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in formulation
- Therapeutic class
- Antiretroviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIDEX | Not yet assigned | — |
Medicinal ingredients
- DIDANOSINE 25 MG per TAB
- DIDANOSINE 50 MG per TAB